Harmony Biosciences Holdings Inc. (HRMY) Social Stream



Harmony Biosciences Holdings Inc. (HRMY): $47.49

2.09 (+4.60%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add HRMY to Watchlist
Sign Up

Industry: Biotech


Ranked

of 384

in industry

HARMONY BIOSCIENCES HOLDINGS INC (HRMY) Price Targets From Analysts

Use the tables below to see what analysts covering HARMONY BIOSCIENCES HOLDINGS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-28 4 $58 $54 $56.5 $45.4 24.45%
2022-02-01 5 $60 $55 $57.4 $45.4 26.43%
2022-03-01 5 $58 $55 $56.8 $45.4 25.11%
2022-04-10 5 $59 $55 $57.2 $45.4 25.99%
2022-05-04 6 $63 $55 $58.166 $45.4 28.12%
2022-05-10 6 $63 $55 $57.833 $45.4 27.39%
2022-07-14 8 $64 $55 $59.125 $45.4 30.23%
2022-08-03 8 $64 $55 $59.125 $45.4 30.23%
2022-08-04 8 $69 $55 $60.75 $45.4 33.81%

The Trend in the Analyst Price Target


Over the past 116 days, HRMY's average price target has gone up $4.08.

Over the past 38 weeks, HRMY's average upside potential has been 36.71%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-09 4 58 54 56.500 42.18 33.95%
2021-11-28 5 58 54 56.500 37.55 50.47%
2021-12-01 5 60 55 57.400 35.55 61.46%
2022-03-03 5 59 55 57.200 41.64 37.37%
2022-08-03 8 64 55 59.125 52.32 13.01%

HRMY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.75 4 2 2 0 0 8

The Trend in the Broker Recommendations


Over the past 153 days, HRMY's average broker recommendation rating worsened by 0.35.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how HARMONY BIOSCIENCES HOLDINGS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -55.02% of that group.
  • HARMONY BIOSCIENCES HOLDINGS INC's upside potential (average analyst target price relative to current price) is higher than 177.71% of Pharmaceutical Products stocks.
  • HARMONY BIOSCIENCES HOLDINGS INC's average analyst price target is higher than 900.96% of Pharmaceutical Products stocks.
  • HRMY has a higher number of analysts covering the stock than 457.46% of stocks in the mid market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to HARMONY BIOSCIENCES HOLDINGS INC are HCM, GBT, and FOLD.

Make investment decisions regarding HRMY using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5921 seconds.